Emerald Acquisition’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
$40.6M Buy
638,425
+46,990
+8% +$2.99M 0.08% 304
2016
Q2
$44M Buy
+591,435
New +$44M 0.08% 304